Delayed hemolytic transfusion reaction in sickle cell disease
- PMID: 20051821
- PMCID: PMC2837790
- DOI: 10.1097/MAJ.0b013e3181c70e14
Delayed hemolytic transfusion reaction in sickle cell disease
Abstract
Delayed hemolytic transfusion reactions are potentially life-threatening complications observed in patients with sickle cell disease. We review the clinical features, pathophysiology, laboratory evaluation, and management of this complication. It is important that delayed hemolytic transfusion reactions be included in the differential diagnosis of acute pain episodes following a red blood cell transfusion in a patient with sickle cell disease.
References
-
- Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood. 1993;81:1109–1123. - PubMed
-
- King KE, Ness PM. Treating anemia. Hematol Oncol Clin North Am. 1996;10:1305–1320. - PubMed
-
- Vichinsky E. Transfusion. In: Embury SH, Embury SH, Hebbel, Mohandas, Steinberg, editors. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press; 1994. pp. 781–798.
-
- Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42:37–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical